Skip to content
HowShorted

SOLENO THERAPEUTICS INC short interest in 2021

In 2021, SOLENO THERAPEUTICS INC's disclosed short interest ran from 1.15% of shares outstanding on 15 Jan 2021 to 0.90% on 31 Dec 2021, a change of -0.25 percentage points. The year's high was 5.65% on 15 Jun 2021 and its low 0.76% on 15 Dec 2021, averaging 2.26% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.39 days on 15 Nov 2021. Full history: SOLENO THERAPEUTICS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SOLENO THERAPEUTICS INC in 2021

2021 in figures

Start of year
1.15% (15 Jan 2021)
End of year
0.90% (31 Dec 2021)
Change
-0.25 pp
High
5.65% (15 Jun 2021)
Low
0.76% (15 Dec 2021)
Average
2.26%
Highest days to cover
8.39 (15 Nov 2021)
SEC filings marked
8

Every report in 2021

SOLENO THERAPEUTICS INC short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20211.15%4.22
29 Jan 20211.27%4.19
12 Feb 20210.97%1.22
26 Feb 20210.96%2.72
15 Mar 20212.17%1.0010-K filed, results (8-K)
31 Mar 20213.08%1.00
15 Apr 20213.00%1.55
30 Apr 20213.51%3.04
14 May 20213.50%3.0110-Q filed, results (8-K)
28 May 20214.77%7.53
15 Jun 20215.65%1.00
30 Jun 20213.05%1.38
15 Jul 20212.90%3.32
30 Jul 20212.47%6.1310-Q filed, results (8-K)
13 Aug 20212.42%4.08
31 Aug 20212.15%6.01
15 Sep 20211.84%2.03
30 Sep 20211.63%4.02
15 Oct 20211.59%6.41
29 Oct 20211.85%6.25
15 Nov 20211.76%8.3910-Q filed, results (8-K)
30 Nov 20210.79%2.49
15 Dec 20210.76%2.39
31 Dec 20210.90%1.71

See also: SOLENO THERAPEUTICS INC's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.